Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 672-673, 2005; 10.1373/clinchem.2004.036368
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lord, R. S.
Right arrow Articles by Bralley, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lord, R. S.
Right arrow Articles by Bralley, J. A.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Pediatric Clinical Chemistry
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2005;51:672-673.)
© 2005 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Significance of Urinary Tartaric Acid

Richard S. Lorda, Cheryl K. Burdette and J. Alexander Bralley

Metametrix Clinical Laboratory, Norcross, GA

aAddress correspondence to this author at: Metametrix Clinical Laboratory, 4855 Peachtree Industrial Blvd, Norcross, GA 30092. Fax 770-441-2237; rslord@metametrix.com.

The first 20% of the full text of this article appears below.


To the Editor:

In 1995, Shaw et al. (1) reported the gas chromatographic–mass spectrometric identification and quantification of various compounds in the urine of two autistic brothers. In that report (1) and a subsequent one (2), the authors concluded that the presence of several compounds, including tartaric acid (excreted as tartarate), may be causally related to the autistic symptoms and that their origin is an overgrowth of intestinal yeast. The practice of analyzing urine for these compounds to detect intestinal yeast continues, although several lines of evidence contradict these conclusions.

Dietary intake is usually the major contributor to urinary tartarate. The US Food and Drug Administration considers it a generally recognized as safe (GRAS) human food ingredient (3). . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.